| Year |
Citation |
Score |
| 2022 |
Wilkerson JL, Alberti LB, Thakur GA, Makriyannis A, Milligan ED. Peripherally administered cannabinoid receptor 2 (CBR) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG. Brain Research. 1774: 147721. PMID 34774500 DOI: 10.1016/j.brainres.2021.147721 |
0.7 |
|
| 2021 |
Bilbrey JA, Ortiz YT, Felix JS, McMahon LR, Wilkerson JL. Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement. Psychopharmacology. PMID 34846548 DOI: 10.1007/s00213-021-06031-2 |
0.364 |
|
| 2021 |
Wilkerson JL, Felix JS, Bilbrey JA, McCurdy CR, McMahon LR. Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine. Pharmacological Reports : Pr. PMID 33860918 DOI: 10.1007/s43440-021-00262-y |
0.305 |
|
| 2020 |
Wilkerson JL, Alberti LB, Kerwin AA, Ledent CA, Thakur GA, Makriyannis A, Milligan ED. Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain. Brain and Behavior. e01850. PMID 32977358 DOI: 10.1002/brb3.1850 |
0.71 |
|
| 2020 |
Wilkerson JL, Jiang J, Felix JS, Bray JK, da Silva L, Gharaibeh RZ, McMahon LR, Schmittgen TD. Alterations in mouse spinal cord and sciatic nerve microRNAs after the chronic constriction injury (CCI) model of neuropathic pain. Neuroscience Letters. 135029. PMID 32380144 DOI: 10.1016/J.Neulet.2020.135029 |
0.348 |
|
| 2018 |
Sim-Selley LJ, Wilkerson JL, Burston JJ, Hauser KF, McLane V, Welch SP, Lichtman AH, Selley DE. Differential Tolerance to FTY720-induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of S1P Receptor Adaptation. The Journal of Pharmacology and Experimental Therapeutics. PMID 29945931 DOI: 10.1124/Jpet.118.248260 |
0.672 |
|
| 2018 |
Curry Z, Wilkerson J, Bagdas D, Kyte S, Patel N, Donvito G, Mustafa MA, Poklis J, Niphakis M, Hsu KL, Cravatt BF, Gewirtz DA, Damaj MI, Lichtman AH. Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy. The Journal of Pharmacology and Experimental Therapeutics. PMID 29540562 DOI: 10.1124/Jpet.117.245704 |
0.594 |
|
| 2018 |
Wilkerson JL, Curry ZA, Kinlow PD, Mason BL, Hsu KL, van der Stelt M, Cravatt BF, Lichtman AH. Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. Pain. PMID 29528965 DOI: 10.1097/J.Pain.0000000000001199 |
0.642 |
|
| 2017 |
Wilkerson JL, Donvito G, Grim TW, Abdullah RA, Ogasawara D, Cravatt BF, Lichtman AH. Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model. The Journal of Pharmacology and Experimental Therapeutics. PMID 28970359 DOI: 10.1124/Jpet.117.243808 |
0.498 |
|
| 2017 |
Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG, Lichtman AH. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28857069 DOI: 10.1038/Npp.2017.204 |
0.759 |
|
| 2016 |
Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R, Maldonado RL, Cravatt BF, Lichtman AH. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Neuropharmacology. PMID 27890602 DOI: 10.1016/J.Neuropharm.2016.11.015 |
0.747 |
|
| 2016 |
Donvito G, Wilkerson JL, Damaj MI, Lichtman AH. Palmitoylethanolamide reverses paclitaxel-induced allodynia in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27608657 DOI: 10.1124/Jpet.116.236182 |
0.572 |
|
| 2016 |
Bagdas D, Wilkerson JL, Kulkarni A, Toma W, AlSharari S, Gul Z, Lichtman AH, Papke RL, Thakur GA, Imad Damaj M. The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain. British Journal of Pharmacology. PMID 27243753 DOI: 10.1111/Bph.13528 |
0.607 |
|
| 2016 |
Wilkerson JL, Ghosh S, Bagdas D, Mason BL, Crowe MS, Hsu KL, Wise LE, Kinsey SG, Damaj MI, Cravatt BF, Lichtman AH. Diacylglycerol lipase beta inhibition reverses nociceptive behavior in mouse models of inflammatory and neuropathic pain. British Journal of Pharmacology. PMID 26915789 DOI: 10.1111/Bph.13469 |
0.766 |
|
| 2016 |
Wilkerson JL, Niphakis MJ, Grim TW, Mustafa MA, Abdullah RA, Poklis JL, Dewey WL, Akbarali HI, Banks ML, Wise LE, Cravatt BF, Lichtman AH. The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model. The Journal of Pharmacology and Experimental Therapeutics. PMID 26791602 DOI: 10.1124/Jpet.115.229971 |
0.751 |
|
| 2015 |
Mukhopadhyay P, Baggelaar M, Erdelyi K, Cao Z, Cinar R, Fezza F, Ignatowska-Jankowska B, Wilkerson J, van Gils N, Hansen T, Ruben M, Soethoudt M, Heitman L, Kunos G, Maccarrone M, et al. The novel, orally available and peripherally restricted selective cannabinoid CB2 -receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. British Journal of Pharmacology. PMID 26398481 DOI: 10.1111/Bph.13338 |
0.75 |
|
| 2015 |
Ignatowska-Jankowska B, Wilkerson JL, Mustafa M, Abdullah R, Niphakis M, Wiley JL, Cravatt BF, Lichtman AH. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice. The Journal of Pharmacology and Experimental Therapeutics. 353: 424-32. PMID 25762694 DOI: 10.1124/Jpet.114.222315 |
0.76 |
|
| 2014 |
Dengler EC, Alberti LA, Bowman BN, Kerwin AA, Wilkerson JL, Moezzi DR, Limanovich E, Wallace JA, Milligan ED. Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain. Journal of Neuroinflammation. 11: 92. PMID 24884664 DOI: 10.1186/1742-2094-11-92 |
0.773 |
|
| 2013 |
Dengler EC, Liu J, Kerwin A, Torres S, Olcott CM, Bowman BN, Armijo L, Gentry K, Wilkerson J, Wallace J, Jiang X, Carnes EC, Brinker CJ, Milligan ED. Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 209-24. PMID 23517784 DOI: 10.1016/J.Jconrel.2013.03.009 |
0.772 |
|
| 2012 |
Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Kuhn MN, Zvonok AM, Thakur GA, Makriyannis A, Milligan ED. Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain and Behavior. 2: 155-77. PMID 22574283 DOI: 10.1002/Brb3.44 |
0.792 |
|
| 2012 |
Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Armijo LM, Kuhn MN, Thakur GA, Makriyannis A, Milligan ED. Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain. 153: 1091-106. PMID 22425445 DOI: 10.1016/J.Pain.2012.02.015 |
0.794 |
|
| 2012 |
Wilkerson J, Alberti L, Wallace J, Kerwin A, Dengler E, Bowman B, Platero P, Thakur G, Makriyannis A, Ledent C, Milligan E. Selective cannabinoid receptor 2 (CB2R) agonist AM1710 acts independently of cannabinoid receptor 1 (CB1R) responses in neuropathic CB1R -/- mice The Journal of Pain. 13: S47. DOI: 10.1016/J.Jpain.2012.01.196 |
0.746 |
|
| 2011 |
Wilkerson JL, Milligan ED. The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief. Isrn Anesthesiology. 2011. PMID 22442754 DOI: 10.5402/2011/593894 |
0.698 |
|
| 2010 |
Brownjohn P, Milligan E, Wilkerson J, Ashton J. 162 IMMUNOHISTOCHEMICAL ANALYSIS OF CB2 RECEPTOR PROTEIN IN THE SPINAL CORD OF NEUROPATHIC RATS TREATED WITH THE CB2-SELECTIVE AGONIST GW405833 European Journal of Pain Supplements. 4: 48-49. DOI: 10.1016/S1754-3207(10)70167-X |
0.668 |
|
| 2010 |
Gentry KR, Wallace JA, Dengler EC, Wilkerson JL, Candelaria GA, Norenberg JP, Milligan ED. Macrophage recruitment to the spinal cord following intrathecal injection: A mechanism to enhance gene therapy as a treatment of neuropathic pain Journal of Critical Care. 25: e17-e18. DOI: 10.1016/J.Jcrc.2010.08.022 |
0.781 |
|
| 2009 |
Ashton J, Brownjohn P, Wilkerson J, Dowie M, Glass M, Milligan E. 166 INTRATHECAL INJECTION OF A CANNABINOID CB2 RECEPTOR SELECTIVE AGONIST GW405833 BLOCKS INDUCTION OF ALLODYNIA BY SCIATIC INFLAMMATORY NEURITIS (SIN) European Journal of Pain. 13. DOI: 10.1016/S1090-3801(09)60169-5 |
0.642 |
|
| 2009 |
Wilkerson J, Dengler E, Thakur G, Wallace J, Zvonok A, Makriyannis A, Ashton J, Milligan E. Administration of AM 1241, a cannabinoid 2 (CB2) receptor selective agonist, to the rodent spinal cord reverses Chronic Constriction Injury (CCI) induced allodynia The Journal of Pain. 10: S22. DOI: 10.1016/J.Jpain.2009.01.095 |
0.776 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Ortiz YT, Bilbrey JA, Felix JS, Kienegger EA, Mottinelli M, Mukhopadhyay S, McCurdy CR, McMahon LR, Wilkerson JL. Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice. Pharmacological Reports : Pr. PMID 37243887 DOI: 10.1007/s43440-023-00498-w |
0.3 |
|
| 2021 |
Blanton HL, Barnes RC, McHann MC, Bilbrey JA, Wilkerson JL, Guindon J. SEX DIFFERENCES AND THE ENDOCANNABINOID SYSTEM IN PAIN. Pharmacology, Biochemistry, and Behavior. 173107. PMID 33444598 DOI: 10.1016/j.pbb.2021.173107 |
0.286 |
|
| 2022 |
Obeng S, León F, Patel A, Zuarth Gonzalez JD, Da Silva LC, Restrepo LF, Gamez-Jimenez LR, Ho NP, Guerrero Calvache MP, Pallares VL, Helmes JA, Shiomitsu SK, Soto PL, McCurdy CR, McMahon LR, ... Wilkerson JL, et al. Interactive Effects of µ-Opioid and Adrenergic-α Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine. The Journal of Pharmacology and Experimental Therapeutics. PMID 36153006 DOI: 10.1124/jpet.122.001192 |
0.272 |
|
| 2021 |
Hiranita T, Obeng S, Sharma A, Wilkerson JL, McCurdy CR, McMahon LR. In vitro and in vivo pharmacology of kratom. Advances in Pharmacology (San Diego, Calif.). 93: 35-76. PMID 35341571 DOI: 10.1016/bs.apha.2021.10.001 |
0.257 |
|
| 2023 |
Luque-Sanchez K, Felix J, Bilbrey J, Restrepo L, Reeves M, McMahon LR, Wilkerson JL. Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model. Advances in Drug and Alcohol Research. 3: 11622. PMID 38389808 DOI: 10.3389/adar.2023.11622 |
0.253 |
|
| 2020 |
Obeng S, Wilkerson JL, León F, Reeves ME, Restrepo LF, Gamez-Jimenez LR, Patel A, Pennington AE, Taylor VA, Ho NP, Braun T, Fortner JD, Crowley ML, Williamson MR, Pallares VL, et al. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for Mu-Opioid Receptor and Opioid-Like Behavioral Effects in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 33384303 DOI: 10.1124/jpet.120.000189 |
0.236 |
|
| 2024 |
Shahbazi Nia S, Ortiz YT, Zuarth Gonzalez JD, Shamir L, Frimpong-Manson K, Hossain MA, Shahi S, Bandy R, Bhat A, Patel D, Diab H, Thompson J, McMahon LR, Wilkerson JL, German NA. Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence Medication. Acs Pharmacology & Translational Science. 7: 654-666. PMID 38481688 DOI: 10.1021/acsptsci.3c00262 |
0.223 |
|
| 2019 |
Wilkerson JL, Felix JS, Restrepo LF, Ansari MI, Coop A, McMahon LR. The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 31235534 DOI: 10.1124/Jpet.118.255844 |
0.222 |
|
| 2019 |
Hiranita T, Leon F, Felix JS, Restrepo LF, Reeves ME, Pennington AE, Obeng S, Avery BA, McCurdy CR, McMahon LR, Wilkerson JL. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats. Psychopharmacology. PMID 31098655 DOI: 10.1007/S00213-019-05247-7 |
0.222 |
|
| 2022 |
Wilkerson JL, Hiranita T, Koek W, McMahon LR. The discriminative stimulus effects of baclofen and gamma hydroxybutyrate in C57BL/6J mice. Behavioural Pharmacology. 33: 427-434. PMID 35947069 DOI: 10.1097/FBP.0000000000000691 |
0.218 |
|
| 2021 |
Wilkerson JL, Bilbrey JA, Felix JS, Makriyannis A, McMahon LR. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline? Pharmacology, Biochemistry, and Behavior. 206: 173192. PMID 33932409 DOI: 10.1016/j.pbb.2021.173192 |
0.216 |
|
| 2023 |
Kamble SH, Obeng S, León F, Restrepo LF, King TI, Berthold EC, Kanumuri SRR, Gamez-Jimenez LR, Pallares VL, Patel A, Ho NP, Hampson A, McCurdy CR, McMahon LR, Wilkerson JL, et al. . The Journal of Pharmacology and Experimental Therapeutics. PMID 37019472 DOI: 10.1124/jpet.122.001525 |
0.21 |
|
| 2020 |
Wilkerson JL, Deba F, Crowley ML, Hamouda AK, McMahon LR. Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators. Neuropharmacology. 168: 108008. PMID 32113032 DOI: 10.1016/J.Neuropharm.2020.108008 |
0.202 |
|
| 2020 |
Corrie LW, Stokes C, Wilkerson JL, Carroll FI, McMahon LR, Papke RL. Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives. Molecular Pharmacology. PMID 32690626 DOI: 10.1124/Molpharm.120.000037 |
0.192 |
|
| 2022 |
Ortiz YT, McMahon LR, Wilkerson JL. Medicinal Cannabis and Central Nervous System Disorders. Frontiers in Pharmacology. 13: 881810. PMID 35529444 DOI: 10.3389/fphar.2022.881810 |
0.181 |
|
| 2022 |
Zainul Z, Ma B, Koka M, Wilkerson JL, Ortiz YT, Kerosuo L, Chandran V. Novel roles of phentolamine in protecting axon myelination, muscle atrophy, and functional recovery following nerve injury. Scientific Reports. 12: 3344. PMID 35228612 DOI: 10.1038/s41598-022-07253-w |
0.171 |
|
| 2020 |
Grenning AJ, Navaratne PV, Wilkerson JL, Ranasinghe KD, Semenova E, Felix JS, Ghiviriga I, Roitberg A, McMahon LR. Axially-Chiral Cannabinols: A New Platform for Cannabinoid-Inspired Drug Discovery. Chemmedchem. PMID 32061146 DOI: 10.1002/Cmdc.202000025 |
0.137 |
|
| 2024 |
Frimpong-Manson K, Ortiz YT, McMahon LR, Wilkerson JL. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. Frontiers in Molecular Neuroscience. 17: 1355281. PMID 38481473 DOI: 10.3389/fnmol.2024.1355281 |
0.128 |
|
| 2022 |
Wilkerson JL, Basu SK, Stiles MA, Prislovsky A, Grambergs RC, Nicholas SE, Karamichos D, Allegood JC, Proia RL, Mandal N. Ablation of Sphingosine Kinase 1 Protects Cornea from Neovascularization in a Mouse Corneal Injury Model. Cells. 11. PMID 36139489 DOI: 10.3390/cells11182914 |
0.125 |
|
| 2019 |
Wilkerson JL, Schulze DR, McMahon LR. Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments. Plos One. 14: e0209947. PMID 30861005 DOI: 10.1371/Journal.Pone.0209947 |
0.124 |
|
| 2024 |
Norris MK, Tippetts TS, Wilkerson JL, Nicholson RJ, Maschek JA, Levade T, Medin JA, Summers SA, Holland WL. Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease. Molecular Genetics and Metabolism Reports. 39: 101077. PMID 38595987 DOI: 10.1016/j.ymgmr.2024.101077 |
0.12 |
|
| 2020 |
McMahon LR, Obeng S, Oyola JF, McCurdy CR, Wilkerson JL, Hiranita T. The safety profile of mitragynine, the primary constituent in kratom (Mitragyna speciosa), in comparison to morphine in rats Journal of Pharmacological and Toxicological Methods. 105: 106710. DOI: 10.1016/j.vascn.2020.106710 |
0.114 |
|
| 2023 |
Wilkerson JL, Basu SK, Mandal NA. Angiogenesis Model of Cornea to Understand the Role of Sphingosine 1-Phosphate. Methods in Molecular Biology (Clifton, N.J.). 2625: 231-240. PMID 36653647 DOI: 10.1007/978-1-0716-2966-6_20 |
0.112 |
|
| 2019 |
McMahon LR, Hiranita T, Wilkerson JL, Oyala JFL, McCurdy CR. Pharmacological characterization of mitragynine, the primary constituent in Kratom, as a potential medication for opioid use disorder. Journal of Pharmacological and Toxicological Methods. 99: 106595. PMID 31963089 DOI: 10.1016/J.Vascn.2019.05.012 |
0.111 |
|
| 2020 |
de Moura FB, Wilkerson JL, McMahon LR. Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro-β-erythroidine in nicotine-tolerant mice. Brain and Behavior. e01581. PMID 32092237 DOI: 10.1002/Brb3.1581 |
0.109 |
|
| 2017 |
Wilkerson JL, Mandal NA. Angiogenesis Model of Cornea to Understand the Role of Sphingosine 1-Phosphate. Methods in Molecular Biology (Clifton, N.J.). 1609: 267-276. PMID 28660590 DOI: 10.1007/978-1-4939-6996-8_23 |
0.097 |
|
| 2019 |
Chaurasia B, Tippetts TS, Monibas RM, Liu J, Li Y, Wang L, Wilkerson JL, Sweeney CR, Pereira RF, Sumida DH, Maschek JA, Cox JE, Kaddai V, Lancaster GI, Siddique MM, et al. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science (New York, N.Y.). PMID 31273070 DOI: 10.1126/Science.Aav3722 |
0.076 |
|
| 2019 |
Wilkerson JL, Stiles MA, Gurley JM, Grambergs RC, Gu X, Elliott MH, Proia RL, Mandal NA. Sphingosine Kinase-1 Is Essential for Maintaining External/Outer Limiting Membrane and Associated Adherens Junctions in the Aging Retina. Molecular Neurobiology. PMID 30997640 DOI: 10.1007/S12035-019-1599-X |
0.075 |
|
| 2017 |
Hopiavuori BR, Deák F, Wilkerson JL, Brush RS, Rocha-Hopiavuori NA, Hopiavuori AR, Ozan KG, Sullivan MT, Wren JD, Georgescu C, Szweda L, Awasthi V, Towner R, Sherry DM, Anderson RE, et al. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency. Molecular Neurobiology. PMID 29168048 DOI: 10.1007/S12035-017-0824-8 |
0.075 |
|
| 2020 |
Moerke MJ, McMahon LR, Wilkerson JL. More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder. Pharmacological Reviews. 72: 527-557. PMID 32205338 DOI: 10.1124/pr.119.018028 |
0.07 |
|
| 2014 |
Mandal NA, Tran JT, Zheng L, Wilkerson JL, Brush RS, McRae J, Agbaga MP, Zhang K, Petrukhin K, Ayyagari R, Anderson RE. In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4. Investigative Ophthalmology & Visual Science. 55: 2705-13. PMID 24644051 DOI: 10.1167/Iovs.13-13198 |
0.065 |
|
| 2022 |
Simeone CA, Wilkerson JL, Poss AM, Banks JA, Varre JV, Guevara JL, Hernandez EJ, Gorsi B, Atkinson DL, Turapov T, Frodsham SG, Morales JCF, O'Neil K, Moore B, Yandell M, et al. A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia. Npj Genomic Medicine. 7: 43. PMID 35869090 DOI: 10.1038/s41525-022-00314-z |
0.063 |
|
| 2024 |
Wilkerson JL, Tatum SM, Holland WL, Summers SA. Ceramides are Fuel Gauges on the Drive to Cardiometabolic Disease. Physiological Reviews. PMID 38300524 DOI: 10.1152/physrev.00008.2023 |
0.06 |
|
| 2020 |
Wilkerson J, Felix J, Restrepo L, Reeves M, McMahon L. Evaluation of Novel Epibatidine Analogs in Rats Discriminating Nicotine The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07353 |
0.059 |
|
| 2020 |
Navaratne PV, Wilkerson JL, Ranasinghe KD, Semenova E, Felix JS, Ghiviriga I, Roitberg A, McMahon LR, Grenning AJ. Front Cover: Axially Chiral Cannabinols: A New Platform for Cannabinoid‐Inspired Drug Discovery (ChemMedChem 9/2020) Chemmedchem. 15: 727-727. DOI: 10.1002/Cmdc.202000140 |
0.056 |
|
| 2023 |
Li Y, Chaurasia B, Rahman MM, Kaddai V, Maschek JA, Berg JA, Wilkerson JL, Mahmassani ZS, Cox J, Wei P, Meikle PJ, Atkinson D, Wang L, Poss AM, Playdon MC, et al. Ceramides increase fatty acid utilization in intestinal progenitors to enhance stemness and increase tumor risk. Gastroenterology. PMID 37541526 DOI: 10.1053/j.gastro.2023.07.017 |
0.049 |
|
| 2013 |
Guiraldelli MF, Eyster C, Wilkerson JL, Dresser ME, Pezza RJ. Mouse HFM1/Mer3 is required for crossover formation and complete synapsis of homologous chromosomes during meiosis. Plos Genetics. 9: e1003383. PMID 23555294 DOI: 10.1371/journal.pgen.1003383 |
0.047 |
|
| 2023 |
Hopiavuori BR, Masser DR, Wilkerson JL, Brush RS, Mandal NA, Anderson RE, Freeman WM. Isolation of Neuronal Synaptic Membranes by Sucrose Gradient Centrifugation. Methods in Molecular Biology (Clifton, N.J.). 2625: 7-15. PMID 36653629 DOI: 10.1007/978-1-0716-2966-6_2 |
0.036 |
|
| 2017 |
Hopiavuori BR, Masser DR, Wilkerson JL, Brush RS, Mandal NA, Anderson RE, Freeman WM. Isolation of Neuronal Synaptic Membranes by Sucrose Gradient Centrifugation. Methods in Molecular Biology (Clifton, N.J.). 1609: 33-41. PMID 28660571 DOI: 10.1007/978-1-4939-6996-8_4 |
0.036 |
|
| 2007 |
Conrad MN, Lee CY, Wilkerson JL, Dresser ME. MPS3 mediates meiotic bouquet formation in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America. 104: 8863-8. PMID 17495028 DOI: 10.1073/Pnas.0606165104 |
0.03 |
|
| 1954 |
BAKER WW, FETTER TR, WILKERSON JL. Recent advances in surgical correction of ureteral obstruction. Pennsylvania Medical Journal (1928). 57: 349-53. PMID 13155112 |
0.027 |
|
| 1976 |
Wilkerson JL, Guillory WA. Laser-induced phosphorescence of matrix-isolated propynal The Journal of Chemical Physics. 64: 4232-4233. |
0.025 |
|
| 1959 |
TAKARO T, PEASLEY ED, McKEEL MF, WILKERSON JL. Aortic dissection due to translumbar aortography, with recovery following surgery. Archives of Surgery (Chicago, Ill. : 1960). 79: 1023-7. PMID 13836658 DOI: 10.1001/archsurg.1959.04320120165023 |
0.025 |
|
| 1977 |
Wilkerson JL, Guillory WA. Condensed phase photochemistry of acetic acid in the vacuum UV Journal of Photochemistry. 7: 251-261. DOI: 10.1016/0047-2670(77)85003-X |
0.024 |
|
| 1967 |
Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. The Journal of Urology. 97: 840-4. PMID 6025928 |
0.023 |
|
| 2008 |
Rohli RV, Wilkerson JL, Vines NA. Hydroclimatological characteristics and atmospheric circulation anomalies associated with the gulf of Mexico hypoxic zone Physical Geography. 29: 404-423. DOI: 10.2747/0272-3646.29.5.404 |
0.019 |
|
| 1981 |
Bhatnagar R, Wilkerson JL, Smith GR, Guillory WA. Laser-induced temporal and wavelength resolved spectroscopy of the 2Σ--2Π and 2Δ-2Π systems of CH and CD isolated in rare gas matrices Journal of Molecular Spectroscopy. 85: 348-357. DOI: 10.1016/0022-2852(81)90207-1 |
0.011 |
|
| 2012 |
Wilkerson JL, Tauritz DR, Bridges JM. Multi-objective coevolutionary automated software correction Gecco'12 - Proceedings of the 14th International Conference On Genetic and Evolutionary Computation. 1229-1236. DOI: 10.1145/2330163.2330333 |
0.011 |
|
| 1977 |
Wilkerson JL, Guillory WA. Laser-induced temporal and wavelength resolved spectroscopy of the 3Π-3Σ- system of matrix-isolated CNN Journal of Molecular Spectroscopy. 66: 188-191. DOI: 10.1016/0022-2852(77)90209-0 |
0.011 |
|
| 2019 |
Wilkerson JL, Summers SA, Holland WL. Listen to your heart when ceramide's calling for higher glucose. Ebiomedicine. PMID 30738827 DOI: 10.1016/j.ebiom.2019.02.004 |
0.01 |
|
| 2011 |
Wilkerson JL, Tauritz DR. Scalability of the coevolutionary automated software correction system Genetic and Evolutionary Computation Conference, Gecco'11 - Companion Publication. 243-244. DOI: 10.1145/2001858.2001995 |
0.01 |
|
| 2011 |
Wilkerson JL, Tauritz DR. A guide for fitness function design Genetic and Evolutionary Computation Conference, Gecco'11 - Companion Publication. 123-124. DOI: 10.1145/2001858.2001929 |
0.01 |
|
| 2010 |
Wilkerson JL, Tauritz D. Coevolutionary automated software correction Proceedings of the 12th Annual Genetic and Evolutionary Computation Conference, Gecco '10. 1391-1392. DOI: 10.1145/1830483.1830739 |
0.01 |
|
| 2007 |
Mero CR, Wilkerson JL. Reduge sewer congestion Water Environment and Technology. 19: 44-52. |
0.01 |
|
| 1984 |
Myers DW, Ozarski RG, Richards JR, Wilkerson JL. NOVA LASER-BEAM DIAGNOSTIC DATA ACQUISITION SYSTEM. . 50-51. |
0.01 |
|
| 1978 |
Van Zee RJ, DeVore TC, Wilkerson JL, Weltner W. High spin molecules: ESR and optical spectroscopy of MnH ( 7∑) and MnH2 (6A1) at 4°K The Journal of Chemical Physics. 69: 1869-1875. |
0.01 |
|
| 1977 |
Ferrante RF, Wilkerson JL, Graham WRM, Weltner W. ESR spectra of the MnO, MnO2, MnO3, and MnO 4 molecules at 4°K The Journal of Chemical Physics. 67: 5904-5913. |
0.01 |
|
| 1975 |
Wilkerson JL, Casperson LW. Laser beam deflection by frequency shifting Optics Communications. 13: 117-121. DOI: 10.1016/0030-4018(75)90023-1 |
0.01 |
|
| 1972 |
Allen SD, Wilkerson JL. The importance of glucose-6-phosphate dehydrogenase screening in a urologic practice. The Journal of Urology. 107: 304-5. PMID 5061461 |
0.01 |
|
| 1967 |
Hamburger RJ, Clark JE, Moran JJ, Cohn HE, Wilkerson JL. Symptomatic benign renal mesenchymoma. A case necessitating bilateral nephrectomy. Archives of Internal Medicine. 120: 78-80. PMID 5339239 DOI: 10.1001/archinte.120.1.78 |
0.01 |
|
| 1958 |
FETTER TR, WILKERSON JL. Tumors of the renal pelvis and ureter. The Journal of the International College of Surgeons. 29: 22-40. PMID 13502577 |
0.01 |
|
| Hide low-probability matches. |